Key points are not available for this paper at this time.
Design
Editorial
This editorial discusses a study linking late acute graft-versus-host disease with circulating angiogenic factors.
Late acute (LA) graft-versus-host disease (GVHD) has recently been added to the clinical spectrum of GVHD. In this issue of Blood, Holtan et al (and the Chronic GVHD Consortium) studied LA GVHD in a large prospective cohort and describe its link with circulating angiogenic factors.1
No takes yet. Share an insight, caveat, or question.
Socié et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: